Cargando…

Quantitative measurement of (219)Rn radioactivity in exhaled breath from patients with bone metastasis of castration-resistant prostate cancer treated with (223)RaCl(2)

BACKGROUND: The α-emitting radionuclide radium-223 ((223)Ra) is widely used for the treatment of bone metastasis in patients with castration-resistant prostate cancer. However, (223)Ra decays into radon-219 ((219)Rn) which is a noble-gas isotope, and (219)Rn may escape from patients treated with (22...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ooe, Kazuhiro, Watabe, Tadashi, Kamiya, Takashi, Yoshimura, Takashi, Hosono, Makoto, Shinohara, Atsushi, Hatazawa, Jun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer International Publishing 2019
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6660527/ https://www.ncbi.nlm.nih.gov/pubmed/31350633 http://dx.doi.org/10.1186/s40658-019-0249-8

Ejemplares similares

Comparing absorbed doses and radiation risk of the α-emitting bone-seekers [(223)Ra]RaCl(2) and [(224)Ra]RaCl(2)
por: Lassmann, Michael, et al.
Publicado: (2023)

Assessing the quality of life of patients with metastatic castration-resistant prostate cancer with bone metastases receiving [(223)Ra]RaCl(2) therapy
por: Sraieb, Miriam, et al.
Publicado: (2020)

Nanomicelles of Radium Dichloride [(223)Ra]RaCl(2) Co-Loaded with Radioactive Gold [(198)Au]Au Nanoparticles for Targeted Alpha–Beta Radionuclide Therapy of Osteosarcoma
por: Souza, Bárbara Nayane Rosário Fernandes, et al.
Publicado: (2022)

[(223)Ra] RaCl(2) nanomicelles showed potent effect against osteosarcoma: targeted alpha therapy in the nanotechnology era
por: Yang, Yang, et al.
Publicado: (2022)

Ultrastructural Analysis of Cancer Cells Treated with the Radiopharmaceutical Radium Dichloride ([(223)Ra]RaCl(2)): Understanding the Effect on Cell Structure
por: Diniz Filho, Joel Félix Silva, et al.
Publicado: (2023)

Scintigraphic Load of Bone Disease Evaluated by DASciS Software as a Survival Predictor in Metastatic Castration-resistant Prostate Cancer Patients Candidates to 223RaCl Treatment
por: Frantellizzi, Viviana, et al.
Publicado: (2019)

α-Particle-induced DNA damage tracks in peripheral blood mononuclear cells of [(223)Ra]RaCl(2)-treated prostate cancer patients
por: Schumann, S., et al.
Publicado: (2021)

Temperature effects on alpha radioactivity of $^{223}$Ra
por: Huber, Gerhard, et al.
Publicado: (2006)

The DASciS Software for BSI Calculation as a Valuable Prognostic Tool in mCRPC Treated with 223RaCl2: A Multicenter Italian Study
por: De Feo, Maria Silvia, et al.
Publicado: (2023)

Dosimetry of inhaled (219)Rn progeny
por: Issa, Hamadou, et al.
Publicado: (2021)

$^{223}$Ra nuclear spectroscopy in $^{14}$C cluster radioactivity
por: Hourany, E, et al.
Publicado: (1995)

New isotope $^{227}$Rn and revised halflives for $^{223}$Rn and $^{226}$Rn
por: García-Borge, M J, et al.
Publicado: (1986)

Submarine groundwater discharge data at meter scale ((223)Ra, (224)Ra, (226)Ra, (228)Ra and (222)Rn) in Indian River Bay (Delaware, US)
por: Duque, Carlos, et al.
Publicado: (2019)

New isotope $^{227}$Rn and revised half lives for $^{223}$Rn and $^{226}$Rn
por: Nybø, K
Publicado: (1987)

Octupole collectivity in $^{220}$Rn and $^{224}$Ra
por: Gaffney, Liam Paul
Publicado: (2013)

Response to (223)Ra-dichloride in castration-resistant prostate cancer with bone metastasis: A case report
por: Cabrera, Montserrat Estorch, et al.
Publicado: (2016)

Are $^{221}$Rn and $^{223}$Rn good candidates to search for an atomic EDM? Investigation of their low-energy nuclear level schemes following $\beta$ decay of $^{221}$At and $^{223}$At
por: Scheck, Marcus, et al.
Publicado: (2014)

Ra-223 Treatment for Bone Metastases in Castrate-Resistant Prostate Cancer: Practical Management Issues for Patient Selection
por: Den, Robert B., et al.
Publicado: (2019)

Radiopharmacokinetic modelling and radiation dose assessment of (223)Ra used for treatment of metastatic castration-resistant prostate cancer
por: Höllriegl, Vera, et al.
Publicado: (2021)

Laser isotope separation of (223)Ra
por: Suryanarayana, M. V.
Publicado: (2023)

Preclinical Evaluation of Radiation-Induced Toxicity in Targeted Alpha Therapy Using [(211)At] NaAt in Mice: A Revisit()
por: Liu, Yuwei, et al.
Publicado: (2020)

Discovery of $^{229}$Rn and the structure of the heaviest Rn and Ra isotopes from Penning-trap mass measurements
por: Neidherr, D, et al.
Publicado: (2009)

Fine Structures in $^{14}C$ Emission of $^{223}Ra$ and $^{224}Ra$
por: Hourani, E, et al.
Publicado: (1991)

miRacle of microRNA-Driven Cancer Nanotherapeutics
por: Kara, Goknur, et al.
Publicado: (2022)

(223)Ra-Dichloride in castration-resistant metastatic prostate cancer: improving outcomes and identifying predictors of survival in clinical practice
por: Dizdarevic, Sabina, et al.
Publicado: (2018)

Ra223 in Bone Metastases with Osteolytic Activity
por: Costa, Renato Patrizio, et al.
Publicado: (2018)

Fine structure in 14C emission from 223Ra and 224Ra
por: Hourani, E, et al.
Publicado: (1991)

Cluster emission in the radioactive decay of 223Ac
por: Steyn, G F, et al.
Publicado: (2010)

Pain Outcomes in Patients with Metastatic Castration-Resistant Prostate Cancer Treated with (223)Ra: PARABO, a Prospective, Noninterventional Study
por: Palmedo, Holger, et al.
Publicado: (2023)

cRacle: R tools for estimating climate from vegetation
por: Harbert, Robert S., et al.
Publicado: (2020)

Measurements of octupole collectivity in Rn and Ra nuclei using Coulomb excitation
por: Rapisarda, E, et al.
Publicado: (2012)

Measurement of octupole collectivity in Rn and Ra nuclei using Coulomb excitation
por: Butler, Peter
Publicado: (2013)

Measurements of octupole collectivity in odd-mass Rn, Fr and Ra isotopes
por: Butler, P A, et al.
Publicado: (2010)

Safety and efficacy of radium-223 dichloride in Japanese patients with castration-resistant prostate cancer and bone metastases
por: Uemura, Hiroji, et al.
Publicado: (2017)

The Analysis of (222)Rn and (220)Rn Natural Radioactivity for Local Hazard Estimation: The Case Study of Cerveteri (Central Italy)
por: Voltattorni, Nunzia, et al.
Publicado: (2023)

α‐Emitting cancer therapy using (211)At‐AAMT targeting LAT1
por: Kaneda‐Nakashima, Kazuko, et al.
Publicado: (2021)

Targeted alpha therapy using astatine ((211)At)-labeled phenylalanine: A preclinical study in glioma bearing mice
por: Watabe, Tadashi, et al.
Publicado: (2020)

The role of dosimetry and biological effects in metastatic castration–resistant prostate cancer (mCRPC) patients treated with (223)Ra: first in human study
por: Sciuto, Rosa, et al.
Publicado: (2021)

The prognostic power of inflammatory indices and clinical factors in metastatic castration-resistant prostate cancer patients treated with radium-223 (BIO-Ra study)
por: Bauckneht, Matteo, et al.
Publicado: (2021)

(177)Lu-Prostate-Specific Membrane Antigen Therapy in Patients with Metastatic Castration-Resistant Prostate Cancer and Prior (223)Ra (RALU Study)
por: Rahbar, Kambiz, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_5e9pqtib2joq7htva8dprgamp6